Brief: Alkermes Announces Final Award In Janssen Pharmaceutica Arbitration

Alkermes

06/06/2023 11:11

June 6 (Reuters) - Alkermes Plc  ALKS.O :
    * ALKERMES ANNOUNCES FINAL AWARD IN JANSSEN PHARMACEUTICA
ARBITRATION AND PROVIDES UPDATED FINANCIAL EXPECTATIONS
    * RAISES 2023 REVENUE AND GAAP NET INCOME EXPECTATIONS BY
APPROXIMATELY $425 MILLION
    * SEES 2023 EARNINGS PER SHARE $1.31 - $1.54
    * SEES 2023 NON-GAAP EARNINGS PER SHARE DILUTED $1.34 -
$1.57
    * SEES 2023 TOTAL REVENUE $1,550 MILLION - $1,680 MILLION
    * FY2023 EARNINGS PER SHARE VIEW $0.08, REVENUE VIEW $1.19
BILLION
-- REFINITIV IBES DATA
    * ALKERMES - REITERATED COMMITMENT TO ACHIEVE 2024 ADJUSTED
NET
INCOME MARGIN OF 25%, EBITDA MARGIN OF 20%, OF CO'S TOTAL
REVENUE (EX ROYALTY REVENUE FROM JANSSEN)
    * REITERATED FY 2025 NON-GAAP NET INCOME MARGIN OF 30%, &
EBITDA
MARGIN OF 25%, OF CO'S TOTAL REVENUES (EX ROYALTY REVENUE FROM
JANSSEN)

Source text for Eikon:  ID:nPn5hLfsna 
Further company coverage:  ALKS.O